SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 26th, 2018 • Sun BioPharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 26th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 20, 2018 (the “Effective Date”), among Sun BioPharma, Inc., a Delaware corporation (the “Company”), and those purchasers listed on the attached Schedule I as such schedule may be amended from time to time (each, including its successors and assigns, an “Investor” and collectively the “Investors”).